Summit Therapeutics Inc
0.07 (4.29%)


Draw Mode:

Volume 1,787,960
Bid Price 1.69
Ask Price 1.74
News -
Company Name Stock Ticker Symbol Market Type
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.07 4.29% 1.70 19:42:23
Open Price Low Price High Price Close Price Prev Close
1.63 1.6101 1.75 1.75 1.63
Trades Volume VWAP Dollar Volume Avg Volume
4,443 1,787,960  1.68  3,005,875 -
Last Trade Time Type Quantity Stock Price Currency
19:43:45 2  1.74 USD

Summit Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 139.74M 82.20M 524.52M  705.00k  - -0.42 27.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - 70.90%

more financials information »

News Summit Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SMMT Message Board. Create One! See More Posts on SMMT Message Board See More Message Board Posts

SMMT Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.